Biological Products, (No Diagnostic Substances) · DE · CIK 1787297
Passage BIO, Inc. develops one-time gene therapies for neurodegenerative diseases
Comparable business profile · signals at a glance
Open-market buys & sells (Form 4) · trailing 12 months
Open-market buys & sells (Form 4, transaction codes P/S), aggregated per insider over the trailing 12 months. Source: SEC structured insider data.